ESSA Pharma Inc.: cashflow_operating
| Value | {"amount": -13604966, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-10-01 – 2024-03-31 |
| Status | current |
| Entity | ESSA Pharma Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:47:48.155835+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/5cd2f960-8822-48c8-8a86-6919b91865eb
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001558370-24-008053 · Open the official SEC filing →Retrieved: 2026-08-19T16:47:48.155835+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001633932/cashflow-operating/2024-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/5cd2f960-8822-48c8-8a86-6919b91865eb
History
- no predecessors — first report